Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?

Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?

Hepatitis C virus (HCV) infection is a significant risk factor for liver cirrhosis and hepatocellular carcinoma (HCC). Traditionally, the primary prevention strategy for HCV-associated HCC has focused on removing infection through antiviral regimes. Currently, highly effective direct-acting antivira...

Full description

Bibliographic Details
Main Authors: Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro Campanini, Alessandro Maria Berton, Alessia Ciancio, Mario Pirisi
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
direct-acting antiviral agents
hepatitis C virus
hepatocellular carcinoma
interferon
liver carcinogenesis
sustained virological response
Online Access:https://www.mdpi.com/1999-4915/16/12/1899

Internet

https://www.mdpi.com/1999-4915/16/12/1899

Similar Items